NCT06967038 Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome Status RECRUITING Phase PHASE1/PHASE2
NCT06954805 Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) Status RECRUITING Phase PHASE2
NCT06944119 Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06923397 Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial Status RECRUITING Phase NA
NCT06915246 A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma Status RECRUITING Phase PHASE2
NCT06895538 Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy Status RECRUITING Phase PHASE2/PHASE3
NCT06892119 Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT06883526 Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT06867536 Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden Status RECRUITING Phase PHASE2
NCT06860880 Combating Cancer-Related Fatigue: A Personalized Supportive Care Program Status RECRUITING Phase NA
NCT06859424 A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation Status RECRUITING Phase PHASE2
NCT06856226 Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant Status RECRUITING Phase N/A
NCT06854003 BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma Status RECRUITING Phase PHASE2
NCT06848738 Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound Status ENROLLING_BY_INVITATION Phase NA
NCT06826118 Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma Status RECRUITING Phase PHASE2
NCT06817759 Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer Status NOT_YET_RECRUITING Phase NA